Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study

Abstract Purpose Epilepsy is a common complication of gliomas. The diagnosis of nonconvulsive status epilepticus (NCSE) is challenging because it causes impaired consciousness and mimics glioma progression. NCSE complication rate in the general brain tumor patient population is approximately 2%. How...

Full description

Bibliographic Details
Main Authors: Azumi Kaneoka, Satoka Hashimoto Fujimoto, Kaoru Tamura, Motoki Inaji, Taketoshi Maehara
Format: Article
Language:English
Published: Springer 2023-03-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-023-00632-3
_version_ 1797864337107320832
author Azumi Kaneoka
Satoka Hashimoto Fujimoto
Kaoru Tamura
Motoki Inaji
Taketoshi Maehara
author_facet Azumi Kaneoka
Satoka Hashimoto Fujimoto
Kaoru Tamura
Motoki Inaji
Taketoshi Maehara
author_sort Azumi Kaneoka
collection DOAJ
description Abstract Purpose Epilepsy is a common complication of gliomas. The diagnosis of nonconvulsive status epilepticus (NCSE) is challenging because it causes impaired consciousness and mimics glioma progression. NCSE complication rate in the general brain tumor patient population is approximately 2%. However, there are no reports focusing on NCSE in glioma patient population. This study aimed to reveal the epidemiology and features of NCSE in glioma patients to enable appropriate diagnosis. Methods We enrolled 108 consecutive glioma patients (45 female, 63 male) who underwent their first surgery between April 2013 and May 2019 at our institution. We retrospectively investigated glioma patients diagnosed with tumor-related epilepsy (TRE) or NCSE to explore disease frequency of TRE/NCSE and patient background. NCSE treatment approaches and Karnofsky Performance Status Scale (KPS) changes following NCSE were surveyed. NCSE diagnosis was confirmed using the modified Salzburg Consensus Criteria (mSCC). Results Sixty-one out of 108 glioma patients experienced TRE (56%), and five (4.6%) were diagnosed with NCSE (2 female, 3 male; mean age, 57 years old; WHO grade II 1, grade III 2, grade IV 2). All NCSE cases were controlled by stage 2 status epilepticus treatment as recommended in the Clinical Practice Guidelines for Epilepsy by the Japan Epilepsy Society. The KPS score significantly decreased after NCSE. Conclusion Higher prevalence of NCSE in glioma patients was observed. The KPS score significantly decreased after NCSE. Actively taking electroencephalograms analyzed by mSCC may facilitate accurate NCSE diagnosis and improve the activities of daily living in glioma patients.
first_indexed 2024-04-09T22:50:09Z
format Article
id doaj.art-26078016384845f1a229122cc5c1b5b5
institution Directory Open Access Journal
issn 2730-6011
language English
last_indexed 2024-04-09T22:50:09Z
publishDate 2023-03-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj.art-26078016384845f1a229122cc5c1b5b52023-03-22T11:39:23ZengSpringerDiscover Oncology2730-60112023-03-0114111110.1007/s12672-023-00632-3Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective studyAzumi Kaneoka0Satoka Hashimoto Fujimoto1Kaoru Tamura2Motoki Inaji3Taketoshi Maehara4Department of Neurosurgery, Tokyo Medical and Dental UniversityDepartment of Neurosurgery, Tokyo Medical and Dental UniversityDepartment of Neurosurgery, Tokyo Medical and Dental UniversityDepartment of Neurosurgery, Tokyo Medical and Dental UniversityDepartment of Neurosurgery, Tokyo Medical and Dental UniversityAbstract Purpose Epilepsy is a common complication of gliomas. The diagnosis of nonconvulsive status epilepticus (NCSE) is challenging because it causes impaired consciousness and mimics glioma progression. NCSE complication rate in the general brain tumor patient population is approximately 2%. However, there are no reports focusing on NCSE in glioma patient population. This study aimed to reveal the epidemiology and features of NCSE in glioma patients to enable appropriate diagnosis. Methods We enrolled 108 consecutive glioma patients (45 female, 63 male) who underwent their first surgery between April 2013 and May 2019 at our institution. We retrospectively investigated glioma patients diagnosed with tumor-related epilepsy (TRE) or NCSE to explore disease frequency of TRE/NCSE and patient background. NCSE treatment approaches and Karnofsky Performance Status Scale (KPS) changes following NCSE were surveyed. NCSE diagnosis was confirmed using the modified Salzburg Consensus Criteria (mSCC). Results Sixty-one out of 108 glioma patients experienced TRE (56%), and five (4.6%) were diagnosed with NCSE (2 female, 3 male; mean age, 57 years old; WHO grade II 1, grade III 2, grade IV 2). All NCSE cases were controlled by stage 2 status epilepticus treatment as recommended in the Clinical Practice Guidelines for Epilepsy by the Japan Epilepsy Society. The KPS score significantly decreased after NCSE. Conclusion Higher prevalence of NCSE in glioma patients was observed. The KPS score significantly decreased after NCSE. Actively taking electroencephalograms analyzed by mSCC may facilitate accurate NCSE diagnosis and improve the activities of daily living in glioma patients.https://doi.org/10.1007/s12672-023-00632-3GliomaEpilepsyNonconvulsive status epilepticus (NCSE)Modified Salzburg Consensus Criteria (mSCC)
spellingShingle Azumi Kaneoka
Satoka Hashimoto Fujimoto
Kaoru Tamura
Motoki Inaji
Taketoshi Maehara
Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study
Discover Oncology
Glioma
Epilepsy
Nonconvulsive status epilepticus (NCSE)
Modified Salzburg Consensus Criteria (mSCC)
title Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study
title_full Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study
title_fullStr Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study
title_full_unstemmed Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study
title_short Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study
title_sort nonconvulsive status epilepticus characteristics in glioma patients a retrospective study
topic Glioma
Epilepsy
Nonconvulsive status epilepticus (NCSE)
Modified Salzburg Consensus Criteria (mSCC)
url https://doi.org/10.1007/s12672-023-00632-3
work_keys_str_mv AT azumikaneoka nonconvulsivestatusepilepticuscharacteristicsingliomapatientsaretrospectivestudy
AT satokahashimotofujimoto nonconvulsivestatusepilepticuscharacteristicsingliomapatientsaretrospectivestudy
AT kaorutamura nonconvulsivestatusepilepticuscharacteristicsingliomapatientsaretrospectivestudy
AT motokiinaji nonconvulsivestatusepilepticuscharacteristicsingliomapatientsaretrospectivestudy
AT taketoshimaehara nonconvulsivestatusepilepticuscharacteristicsingliomapatientsaretrospectivestudy